1. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors
2. , and , Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjects. Drug Metab. Dispos., in press.
3. , , , and , Antipsychotic potential of 5-HT3 antagonists: Preclinical data, in: New Research Directions in the Development of Atypical and Other Novel Antipsychotic Medications, and (Eds), Raven Press, New York, in press.
4. , , , and , Characterization of the novel 5-HT3 antagonists MDL 73147EF and MDL 74156 in NG108-15 neuroblastoma X glioma cells. Submitted for publication.
5. and , Analysis of dolasetron and its reduced metabolite in human plasma by GC/MS and HPLC. Submitted for publication.